Your participation in this multicenter research may help us learn how to stop the progression of mild cognitive impairment (MCI) and Alzheimer’s disease in future generations. Information from the study might, in the future, lead to new treatments or even a cure for Alzheimer’s.
Why are we doing this research study?
Our goal is to determine whether imaging of the brain (through MRI, or PET scans) every six months can help predict and monitor the onset and progression of Alzheimer’s disease. In addition to neuroimaging, the study will collect and test blood and, for some participants, cerebral spinal fluid to determine if biomarkers can predict and monitor the disease. Testing cerebral spinal fluid is the only way to obtain important brain information.
We are looking for persons who:
- Are between 55 and 90 years of age
- Are in good general health with no memory problems OR are in good general health but have memory problems or concerns OR have a diagnosis of early Alzheimer’s disease
- Are fluent in English
- Are willing and able to undergo the test procedures
- Have a study partner – a friend or relative who can accompany the volunteer to all clinic visits or can answer questions over the phone
Your health will be closely monitored by a team of doctors and nurses, at no cost to you. Any new information about your physical health will be shared with you and your physician (you are encouraged to continue seeing your regular doctor). You will receive compensation for your time and costs incurred for travel, parking and meals.
NYU Contact Person:
Miroslaw Brys, MD, PhD
NYU School of Medicine
Center for Brain Health MHL 400,
tel. (212) 263 7563
Click here for the Application.
Through the NIH Foundation, the National Institute on Aging and the
National Institute of Bioimaging and Bioengineering are joined in this
public-private partnership with other Federal agencies, private companies and organizations.